# A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)

> **NCT01034111** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 30 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** Sitagliptin phosphate
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT01034111
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03-01
- **Primary completion:** 2010-10-04
- **Final completion:** 2010-10-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01034111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01034111, "A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01034111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*